Perceptive Advisors LLC is 10% at XTL BIOPHARMACEUTICALS LTD (XTLB). They have made 104 open-market trades across 38 companies since 2007, most recently 2026-08-26.
85 open-market purchases totalling $581.0M since 2007, against 19 sales. Across 64 scored buys the stock is up 12.4% at ninety days, and 9.5 points ahead of the S&P over the same stretch.
66 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 58% | 54% | 50% |
| Avg Move | +2.8% | +3.0% | +12.4% |
| Alpha | +0.2% | +2.4% | +9.5% |
| Scored | 66 | 65 | 64 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 88% | 69% | 67% |
| Avg Move | -11.7% | -7.1% | -4.3% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMTX | BUY | 2026-08-26 | 2026-08-27 | $8.69 | $7.5M | -3.8% | -10.1% | — |
| LYRA | SELL | 2025-11-11 | 2025-11-13 | $3.95 | $294K | -22.0% | +6.5% | -62.9% |
| ACRV | SELL | 2025-04-30 | 2025-05-01 | $1.38 | $2.0M | -18.7% | -20.1% | -5.0% |
| ACRV | SELL | 2025-04-25 | 2025-04-29 | $1.84 | $5.1M | -18.9% | -23.1% | +0.0% |
| ATXS | BUY | 2023-12-21 | 2023-12-22 | $6.20 | $4.6M | +11.4% | +28.1% | +130.7% |
| VRCA | BUY | 2023-12-21 | 2023-12-26 | $6.46 | $3.6M | -8.4% | -18.0% | -26.7% |
| VRCA | BUY | 2023-12-15 | 2023-12-19 | $5.54 | $10.9M | +11.1% | -6.0% | -22.5% |
| SLNO | BUY | 2023-09-26 | 2023-09-28 | $16.96 | $23.9M | -4.5% | -13.0% | +48.3% |
| SLNO | BUY | 2023-06-02 | 2023-06-06 | $5.96 | $1.7M | -16.0% | -22.9% | -26.1% |
| SLNO | BUY | 2023-05-19 | 2023-05-23 | $5.08 | $406K | +7.6% | -14.3% | -20.4% |
| CEMI | BUY | 2023-04-04 | 2023-04-06 | $0.44 | $419K | +1.5% | N/A | N/A |
| VBIV | SELL | 2023-04-04 | 2023-04-06 | $0.14 | $3.0M | -15.4% | -26.7% | -40.3% |
| QTNT | SELL | 2022-10-31 | 2022-11-02 | $0.08 | $1.3M | -31.8% | -66.9% | N/A |
| ALBO | SELL | 2022-10-11 | 2022-10-13 | $22.61 | $19.0M | -7.0% | +2.1% | +105.9% |
| ALDX | BUY | 2022-08-09 | 2022-08-11 | $7.55 | $868K | +1.0% | -9.2% | -27.7% |
| ALDX | BUY | 2022-08-01 | 2022-08-03 | $5.05 | $1.5M | +23.4% | +17.8% | -5.4% |
| ALDX | BUY | 2022-07-29 | 2022-08-02 | $5.03 | $2.2M | +26.0% | +20.6% | -7.9% |
| LYRA | BUY | 2022-04-12 | 2022-04-14 | $4.22 | $50.0M | -21.3% | -35.4% | -24.1% |
| AGRX | BUY | 2021-10-13 | 2021-10-15 | $0.85 | $4.9M | -11.1% | -15.4% | -54.8% |
| ADMA | SELL | 2021-09-24 | 2021-09-29 | $1.25 | $623K | -5.2% | +12.2% | +4.3% |
| CERE | BUY | 2021-08-23 | 2021-08-25 | $27.53 | $9.7M | +21.3% | +4.3% | +10.2% |
| VYNE | SELL | 2021-08-13 | 2021-08-17 | $1.84 | $460K | -1.8% | -6.5% | -23.8% |
| VBIV | SELL | 2021-06-09 | 2021-06-11 | $4.00 | $5.7M | -0.3% | -19.9% | -14.8% |
| ARYA | BUY | 2021-06-03 | 2021-06-03 | $10.05 | $6.6M | N/A | N/A | N/A |
| RXDX | BUY | 2021-03-16 | 2021-03-16 | $19.00 | $16.1M | -22.8% | +5.1% | +0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| VYNE | 5,185,057 | $130.4M |
| DOVA | 3,632,601 | $101.9M |
| MGTX | 10,786,658 | $100.2M |
| ALBO | 2,221,489 | $98.1M |
| ZGNX | 3,476,335 | $92.7M |
| IMTX | 11,246,516 | $75.5M |
| SLDB | 6,749,803 | $37.5M |
| ATXS | 2,392,371 | $30.1M |
| VSAR | 4,102,984 | $29.3M |
| CRNX | 307,648 | $26.1M |
| VRCA | 6,777,566 | $23.9M |
| LJPC | 2,703,611 | $16.8M |
| AGRX | 21,654,485 | $13.0M |
| ALDX | 11,350,085 | $8.0M |
| LPTX | 3,508,771 | $7.2M |
| AEGR | 2,823,426 | $5.6M |
| ARYA | 489,975 | $5.5M |
| ACRX | 6,189,060 | $5.3M |
| ACRV | 3,104,139 | $5.1M |
| QTNT | 7,945,211 | $3.0M |
| VBIV | 45,691,816 | $3.0M |
| ATNX | 13,532,467 | $2.7M |
| ATHA | 329,756 | $2.2M |
| CEMI | 3,868,600 | $1.8M |
| ARYB | 157,295 | $1.6M |
| ADGM | 9,675,684 | $983K |
| MOTS | 3,210,542 | $557K |
| KARD | 20,706 | $270K |
| LYRA | 14,026 | $7K |
| FRNM | 10,871,847 | — |
| OPTR | 113,442 | — |
| PPCO | 6,476,446 | — |
| IDEV | 7,891,067 | — |
| MACM.OB | 6,000 | — |
| TRMS | 2,340,000 | — |
| XTLB | 57,509,110 | — |
| Total | $2.2B |
Shares reported on the most recent Form 4, priced at the 2026-08-27 close. 7 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 16 | 16 | 15 |